Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T16:34:11.044Z.
Calculation as of: 2026-10-06T16:34:11.044Z.
Quote observation: 2026-10-06T16:30:28.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: cae73e0f7d7453288b6b30bb28ae33caa2dcc4a3490ac3f0933bc7bc3ce0e433
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Palvella Therapeutics, Inc.
Market Cap
$1.86B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.86B
Operating Cash Flow Yield
9.47%
TTM Avg
8.87%
3Y Avg
6.19%
5Y Avg
5.71%
Market Cap
$1.83B
Operating Cash Flow Yield
2.07%
TTM Avg
4.97%
3Y Avg
3.70%
5Y Avg
3.22%
Market Cap
$1.84B
Operating Cash Flow Yield
N/A
TTM Avg
0.75%
3Y Avg
4.35%
5Y Avg
3.35%
Market Cap
$1.89B
Operating Cash Flow Yield
0.89%
TTM Avg
1.42%
3Y Avg
1.24%
5Y Avg
1.24%
Market Cap
$1.81B
Operating Cash Flow Yield
4.57%
TTM Avg
3.60%
3Y Avg
2.74%
5Y Avg
2.82%
Market Cap
$1.90B
Operating Cash Flow Yield
N/A
TTM Avg
3.33%
3Y Avg
3.33%
5Y Avg
3.33%
Market Cap
$1.90B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.80B
Operating Cash Flow Yield
0.08%
TTM Avg
0.08%
3Y Avg
0.08%
5Y Avg
0.72%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Palvella Therapeutics, Inc. (PVLA) | $1.86B | N/A | N/A | N/A | N/A |
| Astrana Health, Inc. (ASTH)vs › | $1.86B | 9.47% | 8.87% | 6.19% | 5.71% |
| Azenta, Inc. (AZTA)vs › | $1.83B | 2.07% | 4.97% | 3.70% | 3.22% |
| Novavax, Inc. (NVAX)vs › | $1.84B | N/A | 0.75% | 4.35% | 3.35% |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 0.89% | 1.42% | 1.24% | 1.24% |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.81B | 4.57% | 3.60% | 2.74% | 2.82% |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.90B | N/A | 3.33% | 3.33% | 3.33% |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.90B | N/A | N/A | N/A | N/A |
| Novocure Ltd (NVCR)vs › | $1.80B | 0.08% | 0.08% | 0.08% | 0.72% |
| Immunome, Inc. (IMNM)vs › | $1.92B | N/A | 2.90% | 2.90% | 2.90% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
